New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cibus, Inc.
CBUS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

109M

Biotechnology

Next Earning date - 14 Nov 2024

109M

Biotechnology

Next Earning date - 14 Nov 2024

3.70USD
Shape0.53 ( 16.72%)
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

75%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

84%

Quote Panel

Shape
Updated October 12, 2024
1W 19.74 % 1M -32.48 % 3M -64.32 % 1Y -78.78 %

Key Metrics

Shape
  • Market Cap

    109.12M


  • Shares Outstanding

    29.49M


  • Share in Float

    20.74M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    3.7


  • Average Volume

    195312


  • Beta

    1.818


  • Range

    2.858-23.18


  • Industry

    Biotechnology


  • Website

    https://www.cibus.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

36.85x

P/S Ratio

0.30x

P/B Ratio

0.7

Debt/Equity

-9795.4%

Net Margin

$-3.6

EPS

How CBUS compares to sector?

P/E Ratio

Relative Strength

Shape

CBUS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$8M

Shape879%

2025-Revenue

$2.79

Shape-144%

2025-EPS

$8M

Shape58%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Alliance Global Partners

initialise

Previous: Not converted

2024-07-29

Now: Buy

H.C. Wainwright

upgrade

Previous: Not converted

2023-10-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-6.36
vs -9.80

Q4.22

arrow
arrow

N/A

-2.93
vs -9.22

Q1.23

arrow
arrow

N/A

-1.09
vs -6.69

Q2.23

arrow
arrow

N/A

-3.05
vs -2.66

Q3.23

arrow
arrow

N/A

-1.59
vs -6.36

Q4.23

arrow
arrow

N/A

-1.16
vs -2.93

Q1.24

arrow
arrow

N/A

-1.12
vs -1.09

Q2.24

arrow
arrow

N/A

-1.14
vs -3.05

Q3.24

arrow
arrow

N/A

-0.87
vs -1.59

Q4.24

arrow
arrow

N/A

-0.73
vs -1.16

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-99%

42K  vs 7.8M

Q4.22

arrow
arrow

-98%

42K  vs 1.9M

Q1.23

arrow
arrow

+31%

42K  vs 32K

Q2.23

arrow
arrow

+380%

197K  vs 41K

Q3.23

arrow
arrow

+1031%

475K  vs 42K

Q4.23

arrow
arrow

+2526%

1.1M  vs 42K

Q1.24

arrow
arrow

+1198%

545K  vs 42K

Q2.24

arrow
arrow

+325%

838K  vs 197K

Q3.24

arrow
arrow

+37%

650K  vs 475K

Q4.24

arrow
arrow

-41%

650K  vs 1.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-67%

-0.67
vs -0.18

Q4.22

arrow
arrow

-39%

-0.39
vs -0.67

Q1.23

arrow
arrow

-202%

-2.02
vs -0.39

Q2.23

arrow
arrow

-4%

-0.04
vs -2.02

Q3.23

arrow
arrow

-7%

-0.07
vs -0.04

Q4.23

arrow
arrow

-71%

-0.71
vs -0.07

Q1.24

arrow
arrow

-8%

-0.08
vs -0.71

Q2.24

arrow
arrow

-9%

-0.09
vs -0.08

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News